Susan Kalled
2021
In 2021, Susan Kalled earned a total compensation of $1.8M as Chief Scientific Officer at Compass Therapeutics.
Compensation breakdown
| Bonus | $115,500 |
|---|---|
| Option Awards | $1,446,116 |
| Salary | $220,000 |
| Total | $1,781,616 |
Kalled received $1.4M in option awards, accounting for 81% of the total pay in 2021.
Kalled also received $115.5K in bonus and $220K in salary.
Rankings
In 2021, Susan Kalled's compensation ranked 6,504th out of 12,406 executives tracked by ExecPay. In other words, Kalled earned more than 47.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,504 out of 12,406 | 48th |
Division Manufacturing | 2,789 out of 5,492 | 49th |
Major group Chemicals And Allied Products | 1,230 out of 2,368 | 48th |
Industry group Drugs | 1,097 out of 2,089 | 48th |
Industry Biological Products, Except Diagnostic Substances | 263 out of 452 | 42nd |
Source: SEC filing on April 28, 2022.
Kalled's colleagues
We found two more compensation records of executives who worked with Susan Kalled at Compass Therapeutics in 2021.